Study guide

5.3 Unlicensed Practice, Penalties, and Appeals

Connecticut Multistate Pharmacy Jurisprudence Examination CT MPJE

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 About the Connecticut MPJE 1.2 Application, Fees, ATT, and Pearson VUE 1.3 Blueprint, Scoring, Retakes, and Study Strategy

2 Connecticut Regulatory Structure

2.1 DCP and the Commission of Pharmacy 2.2 Chapter 400j, 420b/420c, and RCSA 20-576 2.3 Federal vs Connecticut Law (More Restrictive Rule)

3 Pharmacist Licensure, Interns, PIC, and CE

3.1 Pharmacist Qualifications and Exam Path 3.2 Interns, Score Transfer, and Reciprocity 3.3 Pharmacist-in-Charge / Pharmacist Manager 3.4 License Renewal and Continuing Education

4 Technicians and Non-Pharmacist Personnel

4.1 Technician Registration and Certification 4.2 Community Technician Ratios (20-576-36) 4.3 Institutional Ratios and Advanced Pharmacy Technicians 4.4 Technician Limitations, Interns, and Unlicensed Staff

5 Discipline, Impairment, and Unlicensed Practice

5.1 Disciplinary Grounds (CGS § 20-579) 5.2 Impaired Practitioner Reporting and Programs 5.3 Unlicensed Practice, Penalties, and Appeals

6 Federal Drug Law Foundations

6.1 FDCA, Adulteration, and Misbranding 6.2 FDA Approval, Recalls, and OTC vs Rx 6.3 DSCSA, HIPAA, OBRA ’90, and PPPA

7 Federal Controlled Substances

7.1 CSA Schedules and Definitions 7.2 DEA Registration and Forms 222, 106, 41 7.3 Federal Controlled-Substance Prescription Rules 7.4 Inventory, Theft, Loss, and Disposal

8 Prescription Issuance in Connecticut

8.1 Who May Prescribe in Connecticut 8.2 Noncontrolled Prescription Form and Content 8.3 Controlled Prescriptions and the EPCS Mandate

9 Refills, Partial Fills, and Opioid Limits

9.1 Refill Authority (Noncontrolled and CIII–V) 9.2 Partial Fills of Schedule II Prescriptions 9.3 Connecticut Opioid Supply Limits (7-day / 5-day)

10 Administration, CDTM, and Standing Orders

10.1 Pharmacist Immunization Authority 10.2 Collaborative Drug Therapy Management 10.3 Naloxone and Opioid Antagonist Access 10.4 Emergency and Hormonal Contraception

11 Counseling, Confidentiality, and Returns

11.1 Counseling and Offer to Counsel 11.2 HIPAA and Connecticut Confidentiality 11.3 Return, Reuse, and Take-Back

12 Corresponding Responsibility and DUR

12.1 Corresponding Responsibility and Legitimate Medical Purpose 12.2 Prospective Drug Utilization Review 12.3 Exceptions and Conditions Prohibiting Dispensing

13 Transfers, Labeling, Packaging, and Delivery

13.1 Transferring Prescriptions 13.2 Labeling of Dispensed Drugs 13.3 Packaging and the Poison Prevention Packaging Act 13.4 Delivery of Drugs

14 CPMRS, Substitution, and Nonprescription Drugs

14.1 CPMRS Query and Reporting 14.2 Generic and Biosimilar Substitution 14.3 CMEA and Behind-the-Counter Products 14.4 OTC Labeling, Hazardous, and Restricted Nonprescription Drugs

15 Ordering, Records, and Inventories

15.1 Ordering and Acquisition (DEA 222/CSOS) 15.2 Distribution and DSCSA Records 15.3 Recordkeeping Content and Three-Year Retention 15.4 Controlled-Substance Inventories and CT Perpetual CII

16 Storage, Security, and Hazardous Drugs

16.1 Controlled-Substance Storage and Security 16.2 Hazardous Drugs (USP <800>, NIOSH) 16.3 Non-Pharmacist Access to Drugs

17 Compounding and Central Fill

17.1 Nonsterile Compounding (USP <795>, RCSA 20-576-69) 17.2 Sterile Compounding (USP <797>, RCSA 20-576-64) 17.3 Central Fill, 503A, and 503B Outsourcing

18 Pharmacy Permits and Practice Settings

18.1 Pharmacy License, Hours, Manager, and Signage 18.2 Nonresident, Hospital, Nuclear, and Automated Dispensing 18.3 Inspection, Closure, and Facility Discipline

5.3 Unlicensed Practice, Penalties, and Appeals

Key Takeaways Explain This Topic AI

CGS § 20-605 prohibits engaging in the practice of pharmacy without a current pharmacist license or temporary permit issued by DCP; CGS § 20-606 is the title statute that lets a conforming pharmacist use “pharmacist.”

CGS § 20-608 fines a pharmacist $100, and exposes the pharmacist to Commission discipline, for permitting an unlicensed person to use the certificate of license, temporary permit, or display document.

CGS § 20-581 makes a Pharmacy Practice Act violation for which no other penalty is provided a class D felony; each violating patient contact or consultation is a separate offense; failure to renew a license on time is not a § 20-581 crime.

A Connecticut class D felony carries imprisonment of not more than five years (CGS § 53a-35a(8)) and a fine of not more than $5,000 (CGS § 53a-41(4)), unless a defining statute sets a different number.

CGS § 20-582 appeals of Commission discipline or refusal go to Superior Court under the UAPA, CGS § 4-183, generally within 45 days after mailing of the final decision; DEA and DCP controlled-substance registrations are separate credentials that can be hit in parallel.

Last updated: August 2026

Why unlicensed practice is tested next to discipline

NABP Area 1.2.2 is not only “what can the board do to a licensee.” It is also who may not practice at all , who may use the title , what the criminal penalty is , and how a final Commission order is reviewed . Connecticut splits those ideas across CGS §§ 20-605, 20-606, 20-608, 20-581, and 20-582 . Mixing them with DEA registration and Connecticut’s controlled-substance registration is the second half of the item.

Quick Answer: No individual may engage in the practice of pharmacy unless the individual holds a current license or temporary permit issued by DCP ( § 20-605 ). A pharmacist who conforms to the commissioner’s regulations may use the title “pharmacist” ( § 20-606 ). Lending the certificate to an unlicensed person is a $100 fine plus Commission discipline ( § 20-608 ). A Chapter 400j violation with no other penalty is a class D felony ; late renewal is not that felony ( § 20-581 ). Appeal the Commission under § 20-582 → § 4-183 (generally 45 days after the final decision is mailed).

Practicing without a license and using the title

CGS § 20-605 is one sentence and is worth a point on almost every CT MPJE form: “No individual may engage in the practice of pharmacy unless the individual holds a current license or temporary permit to practice pharmacy issued by the department.” “Practice of pharmacy” is defined in § 20-571 as the sum of knowledge, procedures, controls, and ethics a pharmacist uses to assure safety and accuracy in distributing, dispensing, and using drugs and devices. A technician, clerk, intern whose card is void, or pharmacist whose license is expired, suspended, or revoked is not holding a current pharmacist license or temporary permit. An intern practicing without a physically present, personally supervising pharmacist is not saved by the intern card; that is RCSA § 20-576-9 plus § 20-605 if the intern is effectively practicing as the pharmacist.

CGS § 20-606 is the title rule, not a second licensing statute: a pharmacist who conforms to the commissioner’s regulations may have, use, and exhibit the title “pharmacist” in the practice of pharmacy. Combined with § 20-609 , a business that is not a licensed pharmacy is prohibited from using words, displays, or symbols indicating it is a pharmacy (with a narrow statutory exemption). § 20-579(a)(18) then makes it a Commission ground to permit an unlicensed person to practice in violation of § 20-605 , to use a license or display document in violation of § 20-608 , or to use pharmacy words or symbols in violation of § 20-609 .

CGS § 20-608 is the “loaned wall license” statute. A pharmacist who permits that pharmacist’s certificate of license, temporary permit, or display document to be used by an unlicensed person for unlawful use shall be fined one hundred dollars and shall be subject to other disciplinary proceedings within the authority of the Commission. The $100 is a specific penalty; it does not replace § 20-579 conditions, suspension, or the $1,000-per-violation civil penalty, and it does not immunize the unlicensed actor from § 20-605 / § 20-581 .

CGS § 20-607 , taught with licensure in Chapter 3, is the inspection companion: the current certificate or temporary permit (or intern or technician registration) must be available for inspection while the person is practicing. An expired intern card in a wallet is not a current pharmacist license.

Criminal penalty — CGS § 20-581

§ 20-581 is the Pharmacy Practice Act’s residual crime:

Any person who violates any provision of §§ 20-570 to 20-631, inclusive, and § 20-635 for the violation of which no other penalty has been provided shall be guilty of a class D felony .

Each instance of patient contact or consultation that violates those sections is a separate offense .

Failure to renew in a timely manner any license issued under those sections is not a violation for purposes of this section .

That last sentence is a classic distractor. A pharmacist whose renewal is a week late has a licensing problem (late fee under § 20-601 , possible practice-while-expired issues under § 20-605 once the credential is no longer current), not a § 20-581 class D felony merely because the renewal was tardy.

§ 20-581 itself does not reprint a dollar amount or a prison term. P.A. 13-258 converted the old “not more than $5,000 or five years” language into the class D felony label. The current numbers therefore come from the penal code, unless a different statute supplies a specific penalty (as § 20-608 does with $100):

CGS § 53a-35a(8) — for a class D felony, a term of imprisonment of not more than five years .

CGS § 53a-41(4) — for a class D felony, a fine of not more than $5,000 .

Do not call § 20-581 a misdemeanor. Do not call the Commission civil penalty of $1,000 in § 20-579 the criminal fine. They are different tools: Commission civil money versus criminal class D felony prosecution.

§ 20-575(c) also lets the Commission, through the Attorney General , seek a Superior Court injunction against ongoing violations, whether or not an adequate remedy at law exists. Unlicensed practice can therefore be a civil injunction , a Commission case against any licensee who aided it, and a § 20-581 prosecution of the person who practiced.

Appeals — CGS § 20-582 and UAPA § 4-183

CGS § 20-582 is short: any person (1) holding a license, permit, or registration under §§ 20-570 to 20-630 who has been disciplined by the Commission , or (2) who has been refused a license, permit, or registration or refused a renewal of a license or permit under those sections, may appeal as provided in CGS § 4-183 .

§ 4-183 is the Uniform Administrative Procedure Act appeal to Superior Court . The person must be aggrieved by a final decision and must have exhausted administrative remedies (a petition for reconsideration is not a prerequisite). The usual clock is forty-five days after mailing of the final decision (or after personal delivery if there is no mailing). The appeal is filed with the clerk of the Superior Court for the judicial district of New Britain or the district where the appellant resides , and a copy is served on the agency (or the Attorney General in Hartford).

Because § 21a-7(a)(1) makes an adverse Commission action a proposed final decision until the Commissioner of Consumer Protection approves, modifies, or rejects it, the § 4-183 clock runs from the final agency decision, not from the night of the Commission vote. Appealing “the Commission minutes” before the commissioner has acted is usually premature.

DEA and DCP controlled-substance registration — parallel, not automatic

A Connecticut pharmacist who dispenses controlled substances holds three independent credentials:

Credential Who issues it Discipline statute

Pharmacist license (or temporary permit) DCP upon Commission authorization CGS § 20-579; hearing path in §§ 21a-7, 21a-8, 21a-9

Connecticut controlled-substance registration Commissioner of Consumer Protection under Chapter 420c CGS § 21a-317 (must obtain); § 21a-322 (commissioner may suspend, revoke, refuse to renew, probate, condition, and assess up to $1,000 per violation of Chapter 420c); § 21a-323 (Chapter 54 hearing; notice by certified mail)

DEA registration DEA under 21 USC §§ 823–824 21 USC § 824 — DEA may suspend or revoke, including if the state license has been suspended, revoked, or denied (§ 824(a)(3))

§ 21a-322(a) lists its own sufficient-cause list. Exam-relevant parallels include furnishing false application information, a drug-related conviction, failure to maintain effective controls against diversion , suspension/revocation/expiration/surrender of the federal CS registration , prescribing or dispensing outside the state or federal schedules, disciplinary action against any professional license , abuse or excessive use of drugs, non-therapeutic CS possession, and failure to account for CS on audit.

Losing the pharmacist license is therefore sufficient cause for DCP to hit the state CS registration under § 21a-322(a)(6) , and it is a federal ground for DEA action under § 824(a)(3) . The reverse is also true: a DEA surrender can be § 21a-322(a)(4) cause against the Connecticut CS registration even if the Commission has not yet finished the § 20-579 case. None of the three cancellations is “automatic at the moment of the Commission vote.” Each body still uses its own notice-and-hearing statute ( § 21a-323 for the state CS registration; 21 USC § 824 and DEA’s order-to-show-cause process for DEA). Teach parallel , not merged .

Realistic Connecticut scenarios

A technician whose intern registration expired introduces herself at the consultation window as “the pharmacist on duty” while the actual pharmacist is at lunch off site , and she performs final verification . That is § 20-605 unlicensed practice, § 20-606 title misuse, and § 20-579(a)(18) as to the pharmacist who permitted it. If she used the pharmacist’s wall certificate or display document, the pharmacist also takes the § 20-608 $100 fine plus Commission proceedings. Each patient she “counseled” can be a separate § 20-581 count if a prosecutor uses the residual felony. Calling the lunch-hour coverage a “tech check-tech break” does not create a Connecticut exception.

A pharmacist whose Connecticut license is revoked for CII diversion keeps using the store’s DEA number the next morning because “only Hartford can touch DEA.” 21 USC § 824(a)(3) authorizes DEA to suspend or revoke when the state license is gone. § 21a-322 authorizes DCP to suspend or revoke the Connecticut CS registration for the same professional-license discipline and for diversion. Three files, one fact pattern.

A pharmacist receives the Commission’s proposed revocation, waits for the commissioner’s final decision, and then has 45 days from mailing to file a § 4-183 appeal. Calling NABP, retaking the MPJE, or emailing Drug Control is not an appeal.

Official anchors

CGS §§ 20-581, 20-582, 20-605, 20-606, 20-608 .

CGS § 4-183 — 45-day Superior Court appeal.

CGS §§ 21a-317, 21a-322, 21a-323 — state controlled-substance registration and its own civil-penalty / hearing path.